Discovery of Anti-MRSA Secondary Metabolites from a Marine-Derived Fungus Aspergillus fumigatus

Methicillin-resistant (MRSA), a WHO high-priority pathogen that can cause great harm to living beings, is a primary cause of death from antibiotic-resistant infections. In the present study, six new compounds, including fumindoline A-C ( - ), 12 , 13 -hydroxy-asperfumigatin ( ), 2- -tryptoquivaline...

Full description

Saved in:
Bibliographic Details
Published inMarine drugs Vol. 20; no. 5; p. 302
Main Authors Zhang, Rui, Wang, Haifeng, Chen, Baosong, Dai, Huanqin, Sun, Jingzu, Han, Junjie, Liu, Hongwei
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 28.04.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methicillin-resistant (MRSA), a WHO high-priority pathogen that can cause great harm to living beings, is a primary cause of death from antibiotic-resistant infections. In the present study, six new compounds, including fumindoline A-C ( - ), 12 , 13 -hydroxy-asperfumigatin ( ), 2- -tryptoquivaline F ( ) and penibenzophenone E ( ), and thirty-nine known ones were isolated from the marine-derived fungus H22. The structures and the absolute configurations of the new compounds were unambiguously assigned by spectroscopic data, mass spectrometry (MS), electronic circular dichroism (ECD) spectroscopic analyses, quantum NMR and ECD calculations, and chemical derivatizations. Bioactivity screening indicated that nearly half of the compounds exhibit antibacterial activity, especially compounds and , and - showed excellent antimicrobial activities against MRSA, with minimum inhibitory concentration (MIC) values ranging from 1.25 to 2.5 μM. In addition, compound showed moderate inhibitory activity against (MIC: 25 μM), compound showed moderate inhibitory activity against (MIC: 50 μM), and compound showed strong inhibitory activity against the hatching of a egg (IC : 2.5 μM).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1660-3397
1660-3397
DOI:10.3390/md20050302